A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
批准号:
10724935
负责人:
Natalia Torres
金额:
$13.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2028-08-31
关键词:
ATAC-seqAction PotentialsActive LearningAcuteAdolescentAdrenergic AgentsAdultAnimal ModelArrhythmiaAtrial FibrillationAutomobile DrivingAwardCRISPR/Cas technologyCalciumCardiacCardiac MyocytesCardiovascular systemCell NucleusCellsChromatinChronicClinicalDataDevelopmentDown-RegulationEconomic BurdenElectrophysiology (science)EventFamilyFishesFoundationsFunctional disorderFundingFutureGene DeletionGene SilencingGenesGenetic Predisposition to DiseaseGenetic TranscriptionGenomicsGoalsHealthcare SystemsHeartHeart AtriumHeart DiseasesHeart failureHeritabilityHomeostasisHospital CostsHumanIndividualIon ChannelKnowledgeLeadershipLinkMaintenanceMapsMeasuresMediatingMentorsMissionModelingMolecularMorbidity - disease rateOpticsOutputPathogenesisPathway interactionsPatientsPredispositionPrevalencePrincipal InvestigatorPropertyRegulationRegulator GenesRegulatory PathwayResearchResearch ActivityRiskRoleSarcoplasmic ReticulumSecureSignal TransductionSmall Interfering RNAStressStrokeSudden DeathSusceptibility GeneTachyarrhythmiasTestingTranscriptTransgenic OrganismsTretinoinUnited States National Institutes of HealthWestern BlottingZebrafishautosomecareercareer developmentclinical practicegenetic variantinduced pluripotent stem cell derived cardiomyocytesinsightmortalitymultidisciplinarymultiple omicsnovelnovel therapeutic interventionpharmacologicresponsesingle-cell RNA sequencingskillsstressortargeted treatmenttherapeutic targettherapeutically effectivetranscription factortranscription factor USFtranscriptional reprogrammingtranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT ABSTRACT
Atrial fibrillation (AF) is the most common clinical cardiac arrhythmia, with a strong component of heritability.
Patients with AF are at significant risk for debilitating complications, such as stroke, heart failure and sudden
death. Emerging evidence suggests that both common and rare genetic variants in cardiac transcription factors
contribute to AF susceptibility. This link between transcription factors and AF offers exciting opportunities to
investigate previously unrecognized pathways to identify novel “upstream” therapeutic targets. We recently
identified the cardiac transcription factor NFATC1 as a novel AF susceptibility gene in a family with autosomal
dominant young-onset AF. The overall goal of this proposal is to explore the molecular and electrophysiological
role of NFATC1 in cardiac excitability. Our central hypothesis is that NFATC1 directly regulates genes involved
in maintaining calcium homeostasis in the atrium. We proposed three specific aims to test this hypothesis: (1)
identify NFATC1 transcriptional effectors linked to calcium homeostasis in atria; (2) establish the
electrophysiological consequences of NFATC1 disruption in atrial cells; and (3) define NFATC1 modulation of
adrenergic signaling in the heart. The output of this project will be a comprehensive understanding of the
transcriptional networks mediated by NFATC1 that impact calcium homeostasis and promote arrhythmogenesis,
laying the foundation for potential future therapies.
The research activities proposed in this career mentored award will provide experiential learning in support of
my career development objectives. These include (1) expanding my skills into genomics research, optical
mapping and new animal models that are more suitable for the study of arrhythmias, (2) strengthen my research
leadership and management skills, and (3) enhance my grantsmanship to secure independent funding.
Achieving these goals will allow me to develop a research career as an independent principal investigator of a
multidisciplinary cardiovascular research lab that makes substantial contributions to understanding the
development of heart disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金